@article{MTMT:34392931,
	title = {Gyógyszerosztó automata: alkalmazás a napi klinikai gyakorlatban [Automatic medication dispenser: application in daily clinical practice]},
	url = {https://m2.mtmt.hu/api/publication/34392931},
	author = {Benkő, Ria and Bíró, Tivadar and Matuz, Mária},
	journal-iso = {ACTA PHARM HUNG},
	journal = {ACTA PHARMACEUTICA HUNGARICA},
	volume = {93},
	unique-id = {34392931},
	issn = {0001-6659},
	year = {2023},
	eissn = {1587-1495},
	pages = {S34-S34},
	orcid-numbers = {Benkő, Ria/0000-0002-8009-8962; Matuz, Mária/0000-0002-7877-2399}
}

@mastersthesis{MTMT:32852532,
	title = {Application of cyclodextrins and mucoadhesive preservative system in ophthalmic formulations [Ciklodextrinek és mukoadhezív tartósító rendszer alkalmazása szemészeti készítmények fejlesztésében]},
	url = {https://m2.mtmt.hu/api/publication/32852532},
	author = {Bíró, Tivadar},
	doi = {10.14232/phd.10873},
	publisher = {SZTE},
	unique-id = {32852532},
	year = {2022}
}

@article{MTMT:31890902,
	title = {New Approach in Ocular Drug Delivery. In vitro and ex vivo Investigation of Cyclodextrin-Containing, Mucoadhesive Eye Drop Formulations},
	url = {https://m2.mtmt.hu/api/publication/31890902},
	author = {Bíró, Tivadar and Bocsik, Alexandra and Jurišić Dukovski, Bisera and Gróf, Ilona and Lovrić, Jasmina and Pannonhalminé Csóka, Ildikó and Deli, Mária Anna and Aigner, Zoltán},
	doi = {10.2147/DDDT.S264745},
	journal-iso = {DRUG DES DEV THER},
	journal = {DRUG DESIGN DEVELOPMENT AND THERAPY},
	volume = {15},
	unique-id = {31890902},
	issn = {1177-8881},
	abstract = {Background: Optimal transcorneal penetration is necessary for ocular therapy; meanwhile, it is limited by the complex structure and defensive mechanisms of the eye. Antimicrobial stability of topical ophthalmic formulations is especially important. According to previous studies, the mostly used preservative, benzalkonium-chloride is irritative and toxic on corneal epithelial cells; therefore, novel non-toxic, antimicrobial agents are required. In this study, prednisolone-containing ophthalmic formulations were developed with expected optimal permeation without toxic or irritative effects. Methods: The toxicity and permeability of prednisolone-containing eye drops were studied on a human corneal epithelial cell line (HCE-T) and ex vivo cornea model. The lipophilic drug is dissolved by the formation of cyclodextrin inclusion complex. Zinc-containing mucoadhesive biopolymer was applied as an alternative preservative agent, whose toxicity was compared with benzalkonium-chloride. Results: As the results show, benzalkonium-chloride-containing samples were toxic on HCE-T cells. The biopolymer caused no cell damage after the treatment. This was confirmed by immunohistochemistry assay. The in vitro permeability was significantly higher in formulations with prednisolone-cyclodextrin complex compared with suspension formulation. According to the ex vivo permeability study, the biopolymer-containing samples had significantly lower permeability. Conclusion: Considering the mucoadhesive attribute of target formulations, prolonged absorption is expected after application with less frequent administration. It can be stated that the compositions are innovative approaches as novel non-toxic ophthalmic formulations with optimal drug permeability.},
	year = {2021},
	pages = {351-360},
	orcid-numbers = {Pannonhalminé Csóka, Ildikó/0000-0003-0807-2781; Deli, Mária Anna/0000-0001-6084-6524}
}

@article{MTMT:31978759,
	title = {Investigation of the permeability and cytotoxicity in novel topical ophthalmic formulations using in vitro and ex vivo models},
	url = {https://m2.mtmt.hu/api/publication/31978759},
	author = {Bíró, Tivadar and Bocsik, Alexandra and Gróf, Ilona and Bisera, Jurisic Dukowski and Jasmina, Lovric and Deli, Mária Anna and Aigner, Zoltán},
	journal-iso = {ACTA PHARM HUNG},
	journal = {ACTA PHARMACEUTICA HUNGARICA},
	volume = {90},
	unique-id = {31978759},
	issn = {0001-6659},
	year = {2020},
	eissn = {1587-1495},
	pages = {86-86},
	orcid-numbers = {Deli, Mária Anna/0000-0001-6084-6524}
}

@misc{MTMT:31342228,
	title = {II. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science. 23-24 January, 2020 : book of abstracts},
	url = {https://m2.mtmt.hu/api/publication/31342228},
	doi = {10.14232/syrptbrs.2020.af},
	editor = {Bíró, Tivadar},
	publisher = {Szegedi Tudományegyetem; Szegedi Tudományegyetem},
	unique-id = {31342228},
	year = {2020}
}

@CONFERENCE{MTMT:31311283,
	title = {In vitro and ex vivo investigation of steroid containing ocular drug delivery systems},
	url = {https://m2.mtmt.hu/api/publication/31311283},
	author = {Bíró, Tivadar and Aigner, Zoltán},
	booktitle = {II. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science},
	doi = {10.14232/syrptbrs.2020.op1},
	unique-id = {31311283},
	year = {2020},
	pages = {6-6}
}

@article{MTMT:30727229,
	title = {Current Approaches to Use Cyclodextrins and Mucoadhesive Polymers in Ocular Drug Delivery—A Mini-Review},
	url = {https://m2.mtmt.hu/api/publication/30727229},
	author = {Bíró, Tivadar and Aigner, Zoltán},
	doi = {10.3390/scipharm87030015},
	journal-iso = {SCI PHARM},
	journal = {SCIENTIA PHARMACEUTICA},
	volume = {87},
	unique-id = {30727229},
	issn = {0036-8709},
	year = {2019},
	eissn = {2218-0532}
}

@misc{MTMT:30461742,
	title = {I. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science},
	url = {https://m2.mtmt.hu/api/publication/30461742},
	doi = {10.14232/syrptbrs.2019.af},
	editor = {Bíró, Tivadar and Pannonhalminé Csóka, Ildikó},
	publisher = {Szegedi Tudományegyetem},
	unique-id = {30461742},
	year = {2019},
	orcid-numbers = {Pannonhalminé Csóka, Ildikó/0000-0003-0807-2781}
}

@{MTMT:30461741,
	title = {Novel ophthalmic formulations to increase the efficacy and stability},
	url = {https://m2.mtmt.hu/api/publication/30461741},
	author = {Bíró, Tivadar and Aigner, Zoltán},
	booktitle = {I. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science},
	doi = {10.14232/syrptbrs.2019.op15},
	unique-id = {30461741},
	year = {2019},
	pages = {18-18}
}

@article{MTMT:30656370,
	title = {Implementation of Patient Reported Outcome Measures (PROMs) in QbD based formulation development in opthalmology},
	url = {https://m2.mtmt.hu/api/publication/30656370},
	author = {Fekete, Helga and Bíró, Tivadar and Soós, Judit and Pallagi, Edina and Aigner, Zoltán and Pannonhalminé Csóka, Ildikó},
	journal-iso = {ACTA PHARM HUNG},
	journal = {ACTA PHARMACEUTICA HUNGARICA},
	volume = {88},
	unique-id = {30656370},
	issn = {0001-6659},
	year = {2018},
	eissn = {1587-1495},
	pages = {206-206},
	orcid-numbers = {Pannonhalminé Csóka, Ildikó/0000-0003-0807-2781}
}